Related Experiment Video

Updated: May 7, 2026

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry
09:31

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry

Published on: March 7, 2019

Cerebral amyloid angiopathy-related inflammation: an emerging disease

M Savoiardo1, A Erbetta, J C Di Francesco

  • 1Department of Neuroradiology, IRCCS Foundation C. Besta Neurological Institute; Milan, Italy - msavoiardo@istituto-besta.it.

The Neuroradiology Journal
|September 25, 2013
PubMed

Insights

Cerebral amyloid angiopathy-related inflammation (CAA-ri) was diagnosed in three elderly patients using MRI to detect microbleeds and APOE genotyping. Steroid treatment led to lesion disappearance and clinical improvement, suggesting a non-invasive diagnostic approach.

Area of Science:

  • Neurology
  • Radiology
  • Genetics

Background:

  • Cerebral amyloid angiopathy-related inflammation (CAA-ri) presents diagnostic challenges.
  • Early diagnosis is crucial for effective management.

Purpose of the Study:

  • To evaluate the utility of MRI and APOE genotyping in diagnosing CAA-ri.
  • To assess the efficacy of steroid treatment for CAA-ri.

Main Methods:

  • Case observation of three elderly patients with neurological deficits.
  • Magnetic Resonance Imaging (MRI) to identify white matter edema and microbleeds.
  • Genetic analysis of APOE genotypes.

Main Results:

  • MRI revealed white matter edema and microbleeds consistent with cerebral amyloid angiopathy (CAA).
  • Genetic analysis showed APOE ε4/ε4 genotype in patients with inflammatory changes.
  • Steroid treatment resulted in complete lesion resolution and clinical improvement.

Conclusions:

  • MRI-detected microbleeds, supported by APOE ε4/ε4 genotyping, strongly suggest CAA-ri.
  • This approach may obviate the need for invasive cerebral biopsy.
  • Steroids are an effective treatment for CAA-ri.

More Related Videos

A Visual Approach for Inducing Dolichoectasia in Mice to Model Large Vessel-Mediated Cerebrovascular Dysfunction04:29

A Visual Approach for Inducing Dolichoectasia in Mice to Model Large Vessel-Mediated Cerebrovascular Dysfunction

Published on: May 17, 2024

In Vitro Assays to Assess Blood-brain Barrier Mesh-like Vessel Formation and Disruption10:36

In Vitro Assays to Assess Blood-brain Barrier Mesh-like Vessel Formation and Disruption

Published on: June 20, 2017

Related Concept Videos

Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...